Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Georg, Richtig"'
Autor:
Georg Richtig, Marina Berger, Max Koeller, Markus Richtig, Erika Richtig, Jörg Scheffel, Marcus Maurer, Frank Siebenhaar
Publikováno v:
PLoS ONE, Vol 18, Iss 7, p e0287547 (2023)
Beall's list is widely used to identify potentially predatory journals. With this study, we aim to investigate the impact of Beall's list on the perception of listed journals as well as on the publication and citation behavior of the scientific commu
Externí odkaz:
https://doaj.org/article/abe839fc2cf642c59d449ee760bf2537
Autor:
Georg Richtig, Melanie Kienzl, Sonja Rittchen, David Roula, Jürgen Eberle, Zina Sarif, Martin Pichler, Gerald Hoefler, Akos Heinemann
Publikováno v:
Biology, Vol 12, Iss 5, p 706 (2023)
Background: Cannabinoids are mainly used for recreational purposes, but also made their way into oncology, since these substances can be taken to increase appetite in tumour cachexia. Since there are some hints in the literature that cannabinoids mig
Externí odkaz:
https://doaj.org/article/42ac9a3f78e5456fae3933322e886bf9
Autor:
Carola Berking, Thomas K Eigentler, Andrea Forschner, Georg Richtig, Erika Richtig, Stefan Diem, Benjamin Weide, Bernhard Klumpp, Claus Garbe, Lukas Flatz, Patrick Terheyden, Lydia Reinhardt, Friedegund Meier, Carmen Loquai, Ulrike Leiter, Van Anh Nguyen, Martin Röcken, Mirjana Ziemer, Nikolaus B Wagner, Max M Lenders, Kathrin Kühl, Fiona André, Milena Dudda, Natalie Ring, Chiara Ebel, Ramon Stäger, Caroline Zellweger, Roland Lang, Michael Paar, Philipp Gussek, Suzan H Stürmer, Susanne Kimeswenger, Angela Oellinger, Maximilian Gassenmaier, Amadeus Schraag, Wolfram Hoetzenecker, Johanna Mangana, Christoffer Gebhardt, Antonio Cozzio
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 5 (2021)
Background Checkpoint inhibitors revolutionized the treatment of metastatic melanoma patients. Although tumor burden and lactate dehydrogenase (LDH) are associated with overall survival (OS), the impact of tumor growth kinetics remains elusive and in
Externí odkaz:
https://doaj.org/article/312f3dbada1340769c33f2cc069c254d
Autor:
Georg Richtig, Markus Richtig, Wolfram Hoetzenecker, Werner Saxinger, Bernhard Lange-Asschenfeldt, Andreas Steiner, Robert Strohal, Christian Posch, Johann W. Bauer, Robert R. Müllegger, Teresa Deinlein, Norbert Sepp, Beatrix Volc-Platzer, Van Anh Nguyen, Matthias Schmuth, Christoph Hoeller, Gudrun Pregartner, Erika Richtig
Publikováno v:
Acta Dermato-Venereologica, Vol 99, Iss 1, Pp 58-62 (2018)
The aim of this study was to assess the knowledge and influence of predatory journals in the field of dermatology in Austria. A total of 286 physicians (50.5% men) completed a questionnaire. The vast majority of subjects read scientific articles (n =
Externí odkaz:
https://doaj.org/article/a2dfc9a0a0384e2492b908782cad5506
Autor:
Christoph Zielinski, Georg Richtig, Erika Richtig, Alexandra Böhm, Christoph Oing, Farastuk Bozorgmehr, Stephan Kruger
Publikováno v:
ESMO Open, Vol 4, Iss 6 (2019)
Introduction Predatory journals harm the integrity of science as principles of ‘good scientific practice’ are bypassed by omitting a proper peer-review process. Therefore, we aimed to explore the awareness of predatory journals among oncologists.
Externí odkaz:
https://doaj.org/article/d3a6b1dd6bca45f781e6726f7bd97336
Autor:
Georg Richtig, Ariane Aigelsreiter, Karl Kashofer, Emina Talakic, Romana Kupsa, Helmut Schaider, Erika Richtig
Publikováno v:
Case Reports in Oncology, Vol 9, Iss 3, Pp 543-546 (2016)
BRAF mutations occur in up to 50% of melanomas. Mutations in the BRAF gene directly influence the patient’s treatment because several inhibitors are available that only target BRAFV600 mutations. Herein, we describe two cases of patients with metas
Externí odkaz:
https://doaj.org/article/c0786b88dedb4e35a0053cb524c9ff4b
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 37
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7297a5a42488131f68fac8b6cbd0c771
https://doi.org/10.1111/jdv.18871
https://doi.org/10.1111/jdv.18871
Autor:
Georg Richtig, Christoph Hoeller, Martin Wolf, Ingrid Wolf, Barbara M Rainer, Günter Schulter, Markus Richtig, Martin R Grübler, Anna Gappmayer, Thomas Haidn, Julian Kofler, Rainer Huegel, Bernhard Lange-Asschenfeldt, Martin Pichler, Stefan Pilz, Akos Heinemann, Erika Richtig
Publikováno v:
PLoS ONE, Vol 13, Iss 10, p e0204729 (2018)
INTRODUCTION:Immunotherapy is a well-established treatment option in patients with metastatic melanoma. However, biomarkers that can be used to predict a response in these patients have not yet been found, putting patients at risk of severe side effe
Externí odkaz:
https://doaj.org/article/eb5fd8ade4584884b0bc8d82f4feb9a2
Autor:
Georg Richtig, Ariane Aigelsreiter, Daniela Schwarzenbacher, Anna Lena Ress, Jan Basri Adiprasito, Verena Stiegelbauer, Gerald Hoefler, Silvia Schauer, Tobias Kiesslich, Peter Kornprat, Thomas Winder, Florian Eisner, Armin Gerger, Herbert Stoeger, Rudolf Stauber, Carolin Lackner, Martin Pichler
Publikováno v:
PLoS ONE, Vol 12, Iss 11, p e0187814 (2017)
SOX9 has been previously shown to be involved in hepatocellular carcinoma (HCC) and other types of cancer. However, prognostic studies so far involved rather small cohorts or lack external validation and experimental data. In this study, we firstly d
Externí odkaz:
https://doaj.org/article/1f6f61e338174534afc22fb7e39a5318
Autor:
Matthew Dankner, Yifan Wang, Rouhi Fazelzad, Benny Johnson, Caroline A. Nebhan, Ibiayi Dagogo-Jack, Nathaniel J. Myall, Georg Richtig, Jillian W.P. Bracht, Marco Gerlinger, Eiji Shinozaki, Takayuki Yoshino, Daisuke Kotani, Jason R. Fangusaro, Oliver Gautschi, Julien Mazieres, Jeffrey A. Sosman, Scott Kopetz, Vivek Subbiah, Michael A. Davies, Anna L. Groover, Ryan J. Sullivan, Keith T. Flaherty, Douglas B. Johnson, Andrea Benedetti, David W. Cescon, Anna Spreafico, George Zogopoulos, April A.N. Rose
Publikováno v:
JCO precision oncology. 6
PURPOSE Non-V600 mutations comprise approximately 35% of all BRAF mutations in cancer. Many of these mutations have been identified as oncogenic drivers and can be classified into three classes according to molecular characteristics. Consensus treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efeefaa6a334fb0c9e11eeda57365dcf
https://pubmed.ncbi.nlm.nih.gov/35977349
https://pubmed.ncbi.nlm.nih.gov/35977349